TripSit home
Chemical Name

Dimethocaine

Aliases

DMC, CMD, Larocaine

Categories

Stimulant, Research-chemical, Habit-forming, Tentative

Summary

Dimethocaine is a synthetic cocaine-derived local anesthetic with stimulant properties. It acts primarily as a dopamine reuptake inhibitor and voltage-gated sodium channel blocker, producing cocaine-like but generally less intense effects. Despite being perceived as milder, it carries substantial cardiovascular and tissue toxicity risks. Metabolism is dominated by NAT2-mediated N-acetylation, with additional contributions from multiple cytochrome P450 enzymes, resulting in significant inter-individual variability and elevated risk for slow acetylators.

Dosage Note

Note: Dimethocaine shows strong inter-individual variability due to NAT2 polymorphism. Redosing and high doses substantially increase cardiovascular and tissue toxicity risk.

Dosages

Chart shows bounded mass ranges in mg. See the table for all doses.

Light

Common

Strong

Insufflated

5-15mg

15-30mg

30-50mg

Durations

Onset

Duration

After Effects

Insufflated

2m to 10m

1h 30m to 3

1 to 6

Effects

Stimulation, Euphoria, Increased alertness, Local numbness, Increased confidence, Tachycardia (increased heart rate), Vasoconstriction, Increased blood pressure, Anxiety, Jaw tension, Insomnia

Sources

Wikipedia contributors. Dimethocaine. Wikipedia, The Free Encyclopedia. https://en.wikipedia.org/wiki/DimethocaineLindauer C. Toxicokinetics of Emerging Drugs of Abuse: In vivo and in vitro studies on the metabolic fate of the cocaine-derived designer drug dimethocaine. Universität des Saarlandes, 2014. https://jahrbib.sulb.uni-saarland.de/bitstream/20.500.11880/21949/1/Dissertation_Lindauer_Dimethocaine_final_hhm.pdfMeyer MR, Lindauer C, Maurer HH. Dimethocaine, a synthetic cocaine derivative: Studies on its in vitro metabolism catalyzed by P450s and NAT2. Toxicology Letters. 2014;225(1):139–146. https://doi.org/10.1016/j.toxlet.2013.11.033